Analysts Set Expectations for Surmodics, Inc.'s Q1 2025 Earnings (NASDAQ:SRDX)
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Equities researchers at Zacks Research boosted their Q1 2025 earnings per share (EPS) estimates for Surmodics in a research note issued on Tuesday, October 31st. Zacks Research analyst D. Dey now anticipates that the company will post earnings of ($0.22) per share for the quarter, up from their […]